STERIS plc (STE) to Issue Quarterly Dividend of $0.57 on March 21st

STERIS plc (NYSE:STE) announced a quarterly dividend on Tuesday, January 28th,RTT News reports. Shareholders of record on Thursday, February 20th will be given a dividend of 0.57 per share by the medical equipment provider on Friday, March 21st. This represents a $2.28 annualized dividend and a yield of 1.03%. The ex-dividend date is Thursday, February 20th.

STERIS has raised its dividend by an average of 9.5% per year over the last three years. STERIS has a payout ratio of 20.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect STERIS to earn $10.05 per share next year, which means the company should continue to be able to cover its $2.28 annual dividend with an expected future payout ratio of 22.7%.

STERIS Trading Down 0.2 %

Shares of STERIS stock opened at $220.66 on Thursday. STERIS has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55. The stock has a market cap of $21.78 billion, a PE ratio of 50.38 and a beta of 0.84. The firm has a fifty day moving average price of $211.90 and a 200 day moving average price of $224.77.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the prior year, the business earned $2.03 earnings per share. The company’s revenue was up 7.3% compared to the same quarter last year. Equities research analysts predict that STERIS will post 9.11 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Piper Sandler raised shares of STERIS from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. JMP Securities restated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Monday, November 18th. Stephens reissued an “overweight” rating and set a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. Finally, StockNews.com lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $262.50.

Insider Buying and Selling

In other news, SVP Cary L. Majors sold 1,682 shares of STERIS stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the sale, the senior vice president now owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is currently owned by company insiders.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.